Alastair Rae

Title: Alastair Rae: Innovator in Plasma Kallikrein Inhibition

Introduction

Alastair Rae is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for plasma kallikrein. With a total of 7 patents to his name, Rae's work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Rae's latest patents include "Inhibitors of plasma kallikrein and uses thereof" and "Plasma kallikrein inhibitors and uses thereof." These inventions provide compounds and compositions that serve as effective inhibitors of plasma kallikrein, showcasing desirable characteristics for therapeutic applications. His innovative approach in this area highlights the importance of targeting specific enzymes in the treatment of diseases.

Career Highlights

Throughout his career, Alastair Rae has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Takeda Pharmaceutical Company Limited and Shire Human Genetic Therapies, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development.

Collaborations

Rae has collaborated with several talented individuals in his field, including Nikolaos Papaioannou and Sarah Jocelyn Fink. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alastair Rae's contributions to the field of plasma kallikrein inhibition demonstrate his commitment to advancing medical science. His patents and collaborations reflect a dedication to innovation that continues to influence the industry.